Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | See Remarks | November 17, 2023 | November 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date November 17, 2023 · Filed November 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,015 |
Reported balance
After 2023-11-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-11-17 · Grant · Acquired 698 · Balance 17,015 F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. F2: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2023. |
| Common StockSEC Table I · non-derivative | Direct | 16,067 |
Reported balance
After 2023-11-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-11-17 · Tax withholding · Disposed 948 · Balance 16,067 F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 15,183 |
Reported balance
After 2023-11-20 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2023-11-20 · Sale · Disposed 884 · Balance 15,183 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.7816 to $105.8350, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021.
F2: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2023.
F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.7816 to $105.8350, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2023 Filed Nov 22, 2023 00:34 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 884 | $105.83 | $93,556.73 |
DisclosureSEC source: 0001209191-23-056395 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,183 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.7816 to $105.8350, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 17, 2023 Filed Nov 22, 2023 00:34 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 948 | $105.68 | $100,184.64 |
DisclosureSEC source: 0001209191-23-056395 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,067 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| November 17, 2023 Filed Nov 22, 2023 00:34 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 698 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-056395 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,015 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. F2 · balance_after: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2023. Read SEC document |
| August 21, 2023 Filed Aug 21, 2023 22:47 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 5,469 | $87.98 | $481,162.62 |
DisclosureSEC source: 0001209191-23-046803 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,290 Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:47 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 6,049 | $88.71 | $536,606.79 |
DisclosureSEC source: 0001209191-23-046803 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,759 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units, market stock units, and restricted stock units. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:47 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 6,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046803 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,808 F2 · shares: Reflects shares released in connection with the vesting of performance stock units and market stock units granted on August 17, 2020, and August 17, 2021. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:47 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 10,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046803 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,074 F1 · shares: Includes (i) 7,881 shares of which one-third of the total number of restricted stock units shall vest on the first anniversary date following the vesting commencement date of August 17, 2023, and one-twelfth of the total number of restricted stock units shall vest each quarter thereafter until fully vested on August 17, 2026, and (ii) 2,814 shares of which one-twelfth of the total number of restricted stock units shall vest each quarter following the vesting commencement date of August 17, 2023, until fully vested on August 17, 2026. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 22:27 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 946 | $91.70 | $86,748.20 |
DisclosureSEC source: 0001209191-23-045078 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,379 Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:13 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 547 | $81.02 | $44,317.94 |
DisclosureSEC source: 0001209191-23-031217 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,325 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:13 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 698 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031217 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,872 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. F2 · balance_after: Includes 23 shares acquired under the Issuer's employee stock purchase plan on March 15, 2023. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 601 | $122.04 | $73,346.04 |
DisclosureSEC source: 0001209191-23-011757 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,151 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 698 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011757 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,752 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 22:43 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 500 | $102.52 | $51,260.00 |
DisclosureSEC source: 0001209191-22-058237 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,054 Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:43 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 547 | $100.27 | $54,847.69 |
DisclosureSEC source: 0001209191-22-058237 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,554 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:43 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 698 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058237 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,101 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. Read SEC document |
| November 07, 2022 Filed Nov 7, 2022 22:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 12,299 | $88.50 | $1,088,461.50 |
DisclosureSEC source: 0001209191-22-055986 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,403 Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 5,778 | $88.60 | $511,930.80 |
DisclosureSEC source: 0001209191-22-055097 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,702 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 7,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055097 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,480 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on October 31, 2019. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 22:16 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 7,705 | $99.01 | $762,872.05 |
DisclosureSEC source: 0001209191-22-052471 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,120 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 22:16 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 14,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052471 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,825 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on October 31, 2019. F2 · balance_after: Includes 22 shares acquired under the Issuer's employee stock purchase plan on September 15, 2022. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 22:08 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 8,188 | $137.09 | $1,122,492.92 |
DisclosureSEC source: 0001209191-22-046905 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,083 Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 22:08 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 8,975 | $138.12 | $1,239,627.00 |
DisclosureSEC source: 0001209191-22-046905 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,271 F4 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units, market stock units, and restricted stock units. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 22:08 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 13,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046905 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,246 F3 · shares: Reflects shares released in connection with the vesting of performance stock units and market stock units granted on August 17, 2020 and August 17, 2021. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 22:08 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 6,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046905 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,805 F1 · shares: One-third of the total number of restricted stock units shall vest on the first anniversary date following the vesting commencement date of August 17, 2022, and one-twelfth of the total number of restricted stock units shall vest each quarter thereafter until fully vested on August 17, 2025. F2 · balance_after: Includes 12 shares acquired under the Issuer's employee stock purchase plan on March 15, 2022. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 23:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 28 | $250.00 | $7,000.00 |
DisclosureSEC source: 0001209191-21-063941 · doc4.xml · nonDerivative · entry 5 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,361 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 23:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,021 | $248.39 | $501,989.52 |
DisclosureSEC source: 0001209191-21-063941 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,389 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248 to $248.70, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 23:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,882 | $247.41 | $465,626.75 |
DisclosureSEC source: 0001209191-21-063941 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,410 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247 to $247.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 23:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 146 | $246.83 | $36,037.52 |
DisclosureSEC source: 0001209191-21-063941 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,292 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246 to $246.94, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 23:21 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 12,289 | $245.08 | $3,011,785.66 |
DisclosureSEC source: 0001209191-21-063941 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,438 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245 to $245.77, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 22:51 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 8,198 | $194.57 | $1,595,084.86 |
DisclosureSEC source: 0001209191-21-062500 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,727 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 22:51 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 8,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-062500 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,925 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on November 13, 2018 and October 31, 2019. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:38 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 9,747 | $179.73 | $1,751,828.31 |
DisclosureSEC source: 0001209191-21-059097 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,129 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of market stock units. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:38 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 18,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059097 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,876 F1 · shares: Reflects shares released in connection with the vesting of market stock units granted on November 13, 2018 and October 31, 2019. F2 · balance_after: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2021. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 21:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 5,382 | $188.43 | $1,014,130.26 |
DisclosureSEC source: 0001209191-21-054285 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,229 Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 22:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 5,326 | $167.74 | $893,383.24 |
DisclosureSEC source: 0001209191-21-052616 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,611 F4 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units, market stock units, and restricted stock units. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 22:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 7,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052616 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,937 F3 · shares: Reflects shares released in connection with the vesting of performance stock units and market stock units granted on August 17, 2020. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 22:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052616 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,075 F1 · shares: One-third of the total number of restricted stock units shall vest on the first anniversary date following the vesting commencement date of August 17, 2021, and one-twelfth of the total number of restricted stock units shall vest each quarter thereafter until fully vested on August 17, 2024. F2 · balance_after: Includes 27 shares acquired under the Issuer's employee stock purchase plan on March 15, 2021. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,575 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 27 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,575 shares Expires 2024-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F17 · derivative.exercise_date: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of April 28, 2017, with the remaining 2/3rds vesting quarterly until fully vested on April 28, 2020. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,575 | $0.00 Strike: $54.36 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 26 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,575 shares Expires 2024-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of January 27, 2017,with the remaining 2/3rds vesting quarterly until fully vested on January 27, 2020. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,575 | $0.00 Strike: $52.57 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 25 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,575 shares Expires 2023-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of October 28, 2016, with the remaining 2/3rds vesting quarterly until fully vested on October 28, 2019. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,725 | $0.00 Strike: $51.95 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 24 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,725 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 29, 2016 date of grant, until fully vested on July 29, 2019. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 7,722 | $123.02 | $949,934.19 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 17 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,860 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123 to $123.14, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,328 | $122.59 | $530,573.85 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 16 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,582 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122 to $122.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,400 | $121.41 | $169,971.34 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 15 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,910 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.95 to $121.91, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,575 | $54.77 | $195,802.75 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 14 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,575 | $54.36 | $194,337.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 13 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,575 | $52.57 | $187,937.75 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 12 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,725 | $51.95 | $141,563.75 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 11 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,725 | $0.00 Strike: $71.55 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 23 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,725 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 29, 2016 date of grant, until fully vested on April 29, 2019. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,725 | $0.00 Strike: $73.31 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 22 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,725 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 29, 2016 date of grant, until fully vested on January 29, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.